Gemcitabine as single agent chemotherapy in elderly patients with stages III-IV non-small cell lung cancer (NSCLC): a phase II study.
about
A Novel Strategy to Improve the Therapeutic Efficacy of Gemcitabine for Non-Small Cell Lung Cancer by the Tumor-Penetrating Peptide iRGDGemcitabine and carboplatin combination chemotherapy for elderly patients with advanced Non-Small Cell Lung Cancer: a feasibility study.Randomized Phase II trial of paclitaxel and carboplatin followed by gemcitabine switch-maintenance therapy versus gemcitabine and carboplatin followed by gemcitabine continuation-maintenance therapy in previously untreated advanced non-small cell lu
P2860
Gemcitabine as single agent chemotherapy in elderly patients with stages III-IV non-small cell lung cancer (NSCLC): a phase II study.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Gemcitabine as single agent ch ...... cer (NSCLC): a phase II study.
@en
Gemcitabine as single agent ch ...... -IV non-small cell lung cancer
@nl
type
label
Gemcitabine as single agent ch ...... cer (NSCLC): a phase II study.
@en
Gemcitabine as single agent ch ...... -IV non-small cell lung cancer
@nl
prefLabel
Gemcitabine as single agent ch ...... cer (NSCLC): a phase II study.
@en
Gemcitabine as single agent ch ...... -IV non-small cell lung cancer
@nl
P2093
P50
P1433
P1476
Gemcitabine as single agent ch ...... cer (NSCLC): a phase II study.
@en
P2093
Antonio Rozzi
Emanuela Magnolfi
Paolo Marchei
Rolando D'Angelillo
Vincenzo Bianco
P304
P407
P577
2002-09-01T00:00:00Z